ADPT
#1621
Adaptive Biotechnologies Corporation - Common Stock
21.0 2 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.19%
Monthly Change
+14.36%
6 month change
+15.81%
Year Change
+21.78%
Previous Close
21.0 6
Open
21.0 2
Low
21.0 2
High
21.0 2
Volume
135
Financials
- Market Capitalization 3.36 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-41.64
Price to sales ratio
8.9
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1614 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.12 USD | -2.24% | +3.12% | +10.15% | +70.14% | 3.39 B USD | ||
| 1617 |  DYN Dyne Therapeutics, Inc. - Common Stock | 23.64 USD | +0.94% | +3.68% | +28.06% | +0.98% | 3.38 B USD | ||
| 1641 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 33.22 USD | -1.77% | -7.54% | +34.93% | +13.22% | 3.27 B USD | ||
| 1661 |  BEAM Beam Therapeutics Inc. - Common Stock | 31.00 USD | -5.14% | -15.07% | +3.85% | +45.27% | 3.19 B USD |
Frequently asked questions about Adaptive Biotechnologies Corporation - Common Stock
What is the Adaptive Biotechnologies Corporation - Common Stock stock price today?
The current price of Adaptive Biotechnologies Corporation - Common Stock (ADPT) is 21.02. Over the past 24 hours, the stock has changed by -0.19%. Follow the ADPT chart for real-time price dynamics.
What is the stock ticker of Adaptive Biotechnologies Corporation - Common Stock?
Adaptive Biotechnologies Corporation - Common Stock trades under the ticker ADPT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Adaptive Biotechnologies Corporation - Common Stock stock going up?
ADPT has changed by -1.64% over the last week, +14.36% over the last month, and +21.78% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Adaptive Biotechnologies Corporation - Common Stock net income for the last quarter?
Adaptive Biotechnologies Corporation - Common Stock reported net income of -20.03 M for the last quarter. The previous quarter showed -13.58 M, which means net income changed by -47.53%.
How many employees does Adaptive Biotechnologies Corporation - Common Stock have?
As of the latest available data, Adaptive Biotechnologies Corporation - Common Stock has 624 employees. Workforce size can provide additional context about the company's scale and operations.
What is Adaptive Biotechnologies Corporation - Common Stock EBITDA?
Adaptive Biotechnologies Corporation - Common Stock EBITDA is -15.51 M, and its EBITDA margin is -21.88%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Adaptive Biotechnologies Corporation - Common Stock stock?
You can buy Adaptive Biotechnologies Corporation - Common Stock (ADPT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Adaptive Biotechnologies Corporation - Common Stock stock?
Investing in Adaptive Biotechnologies Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ADPT chart and related analysis on metatrader.com as part of your research.